BRCA1 mutations and other sequence variants in a population based sample of Australian women with breast cancer

被引:71
作者
Southey, MC
Tesoriero, AA
Andersen, CR
Jennings, KM
Brown, SM
Dite, GS
Jenkins, MA
Osborne, RH
Maskiell, JA
Porter, L
Giles, GG
McCredie, MRE
Hopper, JL
Venter, DJ
机构
[1] Univ Melbourne, Genet Epidemiol Unit, Carlton, Vic 3053, Australia
[2] Peter MacCallum Canc Inst, Dept Pathol & Res, Melbourne, Vic 3000, Australia
[3] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia
[4] New S Wales Canc Council, Canc & Epidemiol Res Unit, Woolloomooloo, NSW 2011, Australia
[5] Anti Canc Council Vic, Canc Epidemiol Ctr, Carlton, Vic 3053, Australia
[6] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand
基金
英国医学研究理事会;
关键词
BRCA1; breast cancer; DNA sequencing; mutations; population prevalence; variants;
D O I
10.1038/sj.bjc.6690008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The frequency, in women with breast cancer, of mutations and other variants in the susceptibility gene, BRCA1, was investigated using a population-based case-control-family study. Cases were women living in Melbourne or Sydney, Australia, with histologically confirmed, first primary, invasive breast cancer, diagnosed before the age of 40 years, recorded on the state Cancer Registries. Controls were women without breast cancer, frequency-matched for age, randomly selected from electoral rolls. Full manual sequencing of the coding region of BRCA1 was conducted in a randomly stratified sample of 91 cases; 47 with, and 44 without, a family history of breast cancer in a first- or second-degree relative. All detected variants were tested in a random sample of 67 controls. Three cases with a (protein-truncating) mutation were detected. Only one case had a family history; her mother had breast cancer, but did not carry the mutation. The proportion of Australian women with breast cancer before age 40 who carry a germline mutation in BRCA1 was estimated to be 3.8% (95% CI 0.3-12.6%). Seven rare variants were also detected, but for none was there evidence of a strong effect on breast cancer susceptibility. Therefore, on a population basis, rare variants are likely to contribute little to breast cancer incidence.
引用
收藏
页码:34 / 39
页数:6
相关论文
共 32 条
[1]   AT-tributable risks? [J].
Bishop, DT ;
Hopper, J .
NATURE GENETICS, 1997, 15 (03) :226-226
[2]  
CLAUS EB, 1991, AM J HUM GENET, V48, P232
[3]  
Clayton D., 1993, STAT MODELS EPIDEMIO
[4]   Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations [J].
Durocher, F ;
ShattuckEidens, D ;
McClure, M ;
Labrie, F ;
Skolnick, MH ;
Goldgar, DE ;
Simard, J .
HUMAN MOLECULAR GENETICS, 1996, 5 (06) :835-842
[5]   Breast cancer genes - What are the real risks? [J].
Easton, D .
NATURE GENETICS, 1997, 16 (03) :210-211
[6]  
Easton DF, 1996, INT J CANCER, V65, P284, DOI 10.1002/(SICI)1097-0215(19960126)65:3&lt
[7]  
284::AID-IJC2&gt
[8]  
3.0.CO
[9]  
2-W
[10]  
EASTON DF, 1993, AM J HUM GENET, V52, P678